Abstract-Slices of the nucleus accumbens, the terminus of the mesolimbic dopaminergic system and the striatum, the terminus of the nigrostriatal dopamin ergic system obtained from rats, were used for analyzing the dopamine releasing effects of TRH and its analog DN-1417 (r-butyrolactone-r-carbonyl-L-histidyl L-prolinamide citrate).
Abstract-Slices of the nucleus accumbens, the terminus of the mesolimbic dopaminergic system and the striatum, the terminus of the nigrostriatal dopamin ergic system obtained from rats, were used for analyzing the dopamine releasing effects of TRH and its analog DN-1417 (r-butyrolactone-r-carbonyl-L-histidyl L-prolinamide citrate).
( On the other hand, both drugs (10-4 M) had no effect on 45Ca2+ uptake into the striatal slices. A Ca2+ ionophore, A-23187 (10-6 M), stimulated 45Ca2+ uptake into slices of the nucleus accumbens and striatum.
Ouabain abolished the DN-1417-, TRH and A-23187 induced effects. These results suggest that DN-1 417 and TRH activate (Na++ K+)-ATPase and stimulate Ca2+ uptake in the presynaptic sites and release DA which stimulates cyclic AMP formation in the postsynaptic sites of the mesolimbic dopaminergic system mainly and causes several central nervous actions.
There are nigrostriatal and mesolimbic pathways in the central nervous dopamin ergic system (1, 2) . The former, which originates from the cell bodies of A 8 and A 9 (substantia nigra) and terminates in the striatum, is thought to be related to stereotypy and circling behavior.
The latter, which originates from the A 10 cell body and terminates in the nucleus accumbens and olfactory tubercle, is thought to be related to locomotor activity (3) (4) (5) .
In a behavioral study in rats, the locomotor stimulatory action of a TRH analog, DN-1417 (r-butyroIactone-r-carbonyl-L-histidyl-L prolinamide citrate), was about ten times more potent than that of TRH. This action seemed to be mediated through a dopami nergic mechanism that enhanced the release of dopamine (DA) from the nucleus ac cumbens, the terminus of nerves in the mesolimbic DA system (6, 7) . In rats with a unilateral lesion in the nigrostriatal DA pathway produced by 6-hydroxydopamine (6-OHDA), 10 times higher doses of DN 1417 and TRH than the doses used in the locomotor experiments, produced circling toward the side of the lesion. This action appeared to be mediated through enhance ment of DA release from the striatum, the terminus of nerves in the nigrostriatal DA system. In the present study, to analyze further the behavioral study described above, the following neurochemical experiments were done using slices of the nucleus accumbens and striatum: (8) . After the incubation was stopped by adding 30 mM EGTA, the slices were centrifuged at 2,000 g for 5 min at 4°C and then rinsed with fresh KRPB twice. The radioactivities of [3H] and [45Ca] in slices dissolved in 0.2 N NaOH were counted by liquid scintillation. A 10 id aliquot of the same solution was assayed for protein using the Folin reagent (9) . To exclude 45Ca2+ uptake into the extracellular space , the uptake of [3H]-mannitol was subtracted from the total 45Ca2+ uptake.
Cyclic AMP formation: Cyclic AMP for mation in the slices was determined by the method of Krueger et al. (10) . The slices, 2.5 mm thick, were chopped twice using a Mcllwain tissue chopper, suspended in KRPB and centrifuged at 2,000 g for 5 min. Wet slices were weighed and resuspended in fresh KRPB to a final volume of 30-40 mg/ ml. A 0.5 ml aliquot of these suspensions was added to tubes, each containing 0.1 ml of KRPB with one of the drugs, and the pre parations were incubated for 15 min at 37°C. After the reaction was terminated by placing the tube in boiling water for 3 min, the supernatant obtained by centrifugation (3,000 g for 5 min) was assayed for cyclic AMP by a radioimmunoassay method using a Yamasa assay kit.
ATPase assay: Enzyme suspensions com prised of 100 /cg protein of P1 (cell debris, nuclei, 800 g for 10 min), P2 (crude mito chondria, 12,000 g for 30 min) or P3 (crude microsome, 100,000 g for 60 min) fractions of the nucleus accumbens and the striatum were used. ATPase activities were measured in a reaction medium consisting of the enzyme suspensions, 5 mM disodium ATP, 5 mM MgC12 and 100 mM Tris-acetate buffer (pH 7.5) with or without 100 mM NaCI and 20 mM KCI in a final volume of 1.0 ml. The mixtures were incubated at 37°C for 20 min, and the enzymatic reactions were terminated by adding 0.5 ml of an ice-cold TCA solution. The inorganic phosphate liberated during the incubation was estimated according to the method of Takahashi (11) .
[3H]-TRH binding: Slices (0.5 mm thick, wet weight 40 mg) and [3H]-TRH (0.5 i Ci/ 20 nmol) in KRPB containing 50 ug bacitracin were incubated for from 15 to 60 min at 37'C. The nonspecific binding was assayed in the presence of 10-3 M TRH. Specific binding was the total binding minus the nonspecific binding. After the incubation was stopped by adding ice-cold KRPB, the slices were centrifuged at 2,000 g for 5 min at 4°C and then rinsed with fresh KRPB twice. The radioactivities of [3H] in the slices dissolved in 0.2 N NaOH were counted by liquid scintillation.
A 10 /,cl aliquot of the same solution was assayed for protein using the Folin reagent (9) . Fig. 1 a, DN-1 (Fig. 1b) . The addition of KCI (5 X10-2 M) stimulated the DA release from slices of the nucleus accumbens and striatum to the same extent.
As shown in Fig. 2 , the omission of Ca2+ from the superfusion medium almost com pletely abolished the DN-1417 (5 X 10-5 M) and TRH (5X10-4 M)-induced DA releasing effects from the nucleus accumbens slices. A Ca2+ ionophore, A-23187 (10-6 M) , stimulated the DA release from the nucleus accumbens slices (Fig. 3a) . The addition of ouabain (5X10-3 M), a (Na++K+) stimulated adenosine triphosphate (ATP) phospho hydrolase [(Na++K+)-ATPase] inhibitor, almost completely abolished the DN-1417 (10-4 M)-, TRH (10-3 M) and A-23187 (10-6 M)-induced DA releasing effects from the nucleus accumbens slices (Fig. 3b) .
Effects on the uptake of Ca 2+: The addition of DN-1417 (10-4 M) or TRH (10-4 M) stimulated 45Ca2+ uptake into the nucleus accumbens slices time-dependently from 1 to 5 min at 30°C incubation (Fig. 4a) . On the other hand, neither of the drugs (10-4 M) had an effect on 45Ca2+ uptake into the striatal slices (Fig. 4b) . A-23187 (10-6 M) stimulated 45Ca2+ uptake into slices of the nucleus accumbens and striatum. DN-1417 (10-6-10-4 M) and TRH (10-6-10-4 M) stimulated 45Ca2+ uptake into the nucleus accumbens slices concentration-dependently at 30°C for 5-min incubation (Table 1) . Effects on cyclic AMP formation: As shown in Table 2 , the addition of DN-1417 (10-6 10-4 M) or TRH (10-5-10-3 M) accelerated cyclic AMP formation in the nucleus ac cumbens, but not in the striatal slices. A 23187 (10-6 M) accelerated cyclic AMP formation in the nucleus accumbens slices (Table 3) . A Ca2+ antagonist, D-600 (10-6 M), almost completely blocked the DN-1417 (10-4 M)-, TRH (10-3 M) and A-23187 (10-6 M)-induced effects (Table 3) . Effects on ATPase activities: As shown in Table 4 , the subcellular distribution of (Na++ K+)-ATPase activities in the nucleus ac cumbens was as follows: crude mitochondria (P2) > crude microsome (P3) > cell debris (Pl) > supernatant (S). The addition of DN 1417 (10-4 M) activated (Na++K+)-ATPase in the P1 fraction, but not in the P2, P3 and S fractions. DN-1417 (10-4 M) also had no effect on Mgt+-dependent ATPase (Mg2+ ATPase) activities in all fractions. Ouabain (5X10-3 M) inhibited (Na++K+)-ATPase activities in the P1, P2 and P3 fractions to about 60 to 80% of the control. This result suggests that the (Na++K+)-ATPase in these fractions is mostly ouabain sensitive. The addition of DN-1417 (10-6-10-4 M) or TRH (10-6-10-4 M) concentration dependently activated (Na++K+)-ATPase in the P1 fraction of the nucleus accumbens, but had little effect on the activity in the P, fraction of the striatum (Table 5) .
Effects on [3H]-TRH binding: The total and non-specific binding (in the presence of TRH 10-3 M) of [3H]-TRH in the nucleus ac cumbens (Fig. 5a ) and striatal slices ( (Fig. 6) .
These results suggest that DN-1417 and TRH activate (Na++K+)-ATPase and stimu late Ca2+ uptake in the presynaptic sites and release DA which stimulates cyclic AMP formation in the postsynaptic sites of the mesolimbic dopaminergic system mainly and causes several central nervous actions (Fig.  7) . 
Discussion
In an earlier behavioral study in rats, DN locomotor actions mediated via enhancing the release of DA from the nucleus accumbens.
In rats with a unilateral lesion in the nigrostriatal DA pathway produced by 6-OHDA, 10 times higher doses of DN-1417 and TRH than those used in the locomotor experiments produced a circling toward the side with lesion by enhancing the release of DA from the striatum (6) . In addition, the bilateral microinjection into the nucleus accumbens of a small dose of DN-1417 (0.5 ,ug) or TRH (10 and 20 ztg) markedly enhanced locomotor activity in rats, whereas the unilateral intra striatal injection of DN-1417 (50 ieg) or TRH (50 i~g) did not induce any circling behavior in intact rats (7). These observations suggest that DN-1417 and TRH have a different affinity for the nucleus accumbens and striatum. (3-MT), in the nucleus ac cumbens and striatum in correspondence with the decreases i n DA; the increases i n 3-MT in the nucleus accumbens are more marked than that in the striatum (20). 3-MT is the first metabolite of DA after it is released into the synaptic cleft; this reaction is catalyzed by catechoI-0-methyltransferase (COMT), which is apparently located at the postsy naptic membranes; 3-MT is then metabolized to homovanilic acid (HVA) by monoamine oxidase (MAO). The increases in 3-MT reflect DA release from the nerve terminal in the nucleus accumbens and striatum. These in vivo results are quite consistent with the present findings; the stimulatory effect of DN-1417 on DA release is more sensitive in the nucleus accumbens than in the striatum. We reported that in vivo or in vitro treatment with DN-1417 increases cyclic AMP levels in various brain regions. Pretreatment with pimozide, a DA receptor blocker, almost completely abolished the DN-1471 -induced effect (21). These changes do not appear to be related to activation of adenylate cyclase by DN-1417. DN-1 417 seems to exert some central nervous system action by increasing the levels of cyclic AMP through endogenous dopaminergic activation.
In the present report, the effects of DN-1417 and TRH on the different sensitivities of DA release between the nucleus accumbens and the striatum are reflected in the cyclic AMP formation.
The addition of 10-6 to 10-4 M of DN-1 417 or TRH concentration-dependently inhibited the [3H]-TRH binding in the nucleus ac cumbens and striatal slices to almost the same extent. This result suggests that DN 1417 and TRH have almost the same affinity for the nucleus accumbens and striatum, but both drugs have a different sensitivity in the process after the TRH binding [(Na++K+)_ ATPase and Ca2+ uptake] in both types of slices. With respect to the brain distribution of immunoreactive DN-1417 after intravenous administration of 2.5 mg/kg, the nucleus accumbens, hypothalamus and hippocampus showed a higher concentration, whereas the striatum showed rather lower levels than other brain regions (22).
